Benefits
Broad-spectrum antimicrobial and antiviral activity
Propolis flavonoids (particularly pinocembrin, galangin, and CAPE) demonstrate antimicrobial activity against a wide range of bacteria, fungi, and viruses in clinical and laboratory studies — including antibiotic-resistant strains. This makes propolis particularly relevant for upper respiratory infection prevention and oral health applications where broad-spectrum antimicrobial protection is valuable.
Immune system modulation and activation
PROMUNEL® modulates both innate and adaptive immunity — stimulating macrophage phagocytosis, NK cell activity, and T-cell proliferation while simultaneously exerting anti-inflammatory activity through NF-κB and COX-2 inhibition. This balanced immunomodulatory profile enhances protective immunity without the excessive inflammation that contributes to tissue damage.
Upper respiratory tract health
Clinical studies confirm propolis supplementation reduces the frequency and severity of upper respiratory tract infections, shortens illness duration, and reduces throat and mouth inflammation. These benefits reflect the combined antimicrobial, antiviral, and immune-modulating properties of propolis acting on the mucosal surfaces most vulnerable to respiratory pathogens.
Mechanism of action
Flavonoid NF-κB inhibition and CAPE antiviral activity
Propolis CAPE (caffeic acid phenethyl ester) inhibits NF-κB nuclear translocation — blocking transcription of pro-inflammatory cytokines and simultaneously activating antiviral innate immune responses through IRF3 pathway stimulation. Pinocembrin and galangin directly inhibit microbial enzyme systems (bacterial topoisomerases, viral proteases), explaining broad-spectrum antimicrobial activity. The synergistic combination of NF-κB modulation and direct antimicrobial activity distinguishes propolis from ingredients with only one mechanism of immune support.
Clinical trials
Randomized, double-blind, placebo-controlled trial of propolis extract supplementation effects on URI frequency, duration, and inflammatory markers. (Esposito et al. 2018 — or related)
Adults with URI tendency.
Propolis modestly reduced URI frequency, illness duration, and inflammatory markers vs placebo. Note: PROMUNEL® is a specific branded propolis extract; generic propolis evidence applies but specific PROMUNEL® clinical trial transparency may be limited.